会议简介：

疫苗创新国际论坛（Vaccine Innovation International Forum 、VIF）将在中国举行，旨在汇集来自世界各地的专家、研究人员、政策制定者和行业领袖，共同合作推进疫苗开发和免疫领域。疫苗在预防和控制传染病方面发挥了至关重要的作用，并继续在维护全球公共卫生方面发挥着重要作用。中国在疫苗研究、开发和生产方面做出了重大贡献，是这一著名盛会的理想主办国。

随着世界面临新出现的传染性威胁和持续的健康挑战，促进疫苗开发领域的国际合作和知识交流至关重要。本次会议将作为一个平台，分享前沿研究成果，讨论创新疫苗技术，解决全球免疫差距，促进疫苗公平分配。

会议亮点：

1. 聚集全球疫苗专家和主要参与者

2. 连接学术界和工业界，加速商业化

3. 提供疫苗开发和生产的最佳实践

4. 享受更灵活的网络机会，以最大限度地提高您的投资回报率

5. 分享研发与关键技术创新前沿话题

6. 寻找更多开放合作的潜在项目

学术顾问委员会：
Bin Wang, CSO, Advaccine/Professor, Fudan University, China
David Weiner, Executive Vice President, Wistar Institute; Professor Emeritus, University of Pennsylvania, USA
Chunlin Xin, Vice President, Cansino Biologics, China
Yuanqing Liu, CSO, Immorna China, China
Heinrich Haas, Former VP, Formulation& Drug delivery, BioNtech, Germany
Alain Bouckenooghe, CSO, Hilleman Laboratories, Singapore
Shaowei Li, Professor, Xiamen University, China
Sergey Arakelov, Sci. Dir., St. Petersburg Scientific Research Institute of Vaccines and Sera of the FMBA of Russia
Kiat Ruxrungtham, Director of Chula VRC, Chulalongkorn University,Thailand
Dexiang Chen, Chairman& General Manager, Maxvax Biology, China
Anna Du, Senior Program Officer, China Country Office, Bill & Melinda Gates Foundation, China
Li Shi, Board Chairman, Immune-Path Bio,China
Sean Du, Head, External R&D Asia Pacific, Global R&D, Sanofi Pasteur, China
Yuan Yuan, China Country Representative, Business & Alliance Management Lead, PATH, China
Petro Terblanche, CEO, Afrigen Biologics, South Africa

早期确认演讲嘉宾：
George Siber, President, Siber Biotechnologies LLC, USA
Rajinder Suri, CEO, DCVMN International, India
Petro Terblanche, CEO, Afrigen Biologics, South Africa
Simon Graham, Professor, The Pirbright Institute, UK
Kar Muthumani, CSO, GeneOne Life Science, USA
Shan Lu, Professor, University of Massachusetts Medical School, USA
Joon Haeng Rhee, Professor, Chonnam National University Medical School, South Korea
Nikolai Petrovsky, Founder, Vaxine, Australia
Hun Kim, President of Global R&BD, SK Bioscience, South Korea
Dal-Hee Min, CTO, Lemonex, South Korea
Kate Antrobus, Chief Investment Officer, Univercells, Belgium
Kiat Ruxrungtham, Director of Chula Vaccine Research Center, Chulalongkorn University, Thailand
Bin Wang, CSO, Advaccine/Professor, Fudan University, China
David Weiner, Executive Vice President, Wistar Institute; Professor Emeritus, University of Pennsylvania, USA
Andrew Wong, BD Director, Walvax/ General Manager, Shanghai Wotai Biotechnology, China
Nicaise Ndembi, Chief Science Advisor, Africa Centres for Disease Control and Prevention, Ethiopia
Jeffrey Ulmer, President, TechImmune, USA
Jicui Dong, Head, Local Production and Assistance Unit Regulation & PQ, Access to Medicines and Health Products Division,WHO, Switzerland
Ramesh Matur, Sr VP, Head R&D, Biological E, India
Kutub Mahmood, Scientific Director at PATH, USA
Ed Lavelle, Professor, Trinity College Dublin, Ireland
Mahesh Kumar, Senior Vice President, Global Biologics R&D, Zoetis, USA
Abdul Muktadir, Chairman and Managing Director, Incepta Pharmaceuticals/ Incepta Vaccine, Bangladesh
Francesco Berlanda Scorza,VP R&D, Global Health R&D Vaccines Head and GVGH Institute, GSK, Belgium
Baoming Jiang, Senior Scientist, Division of Viral Diseases- CDC, USA
James Wai Kuo Shih, Senior Advisor, Xiamen Innovax Biotech, ChinaHaibo Li, Professor, Army Medical University, China
Ken Ishii, Director, International Vaccine Design Center, Professor, University of Tokyo, Japan
Yu-shen Hsu, Chairman/Acting President, Advagene, Taiwan, China
Frank Chang, CSO, Reber Genetics, Taiwan, China
Shibo Jiang, Professor, Fudan University, China
Zoltan Kis, Lecturer, University of Sheffield, UK
Jeff Zhu, CEO, Reinovax Biologics, China
Michel De Wilde, Owner, MDW Consultant,LLC, Former SVP of R&D, Sanofi Pasteur, USA
Zhizheng Hu, Associate Director, RA, MSD
持续更新中

为何参加：

往届回顾

来源链接：https://www.vaccineforum.cn